Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT06299033
A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 9, 2023
Completion: Dec 30, 2025
Loading map...